James Ingebrand has been appointed vice president and general manager of 3M Drug Delivery Systems. He replaces James Vaughan who is retiring. Mr. Ingebrand has a 27-year career at 3M, with significant insight into the pharmaceutical and health care industries. Mr. Ingebrand will assume responsibility for the strategic direction of the company’s inhalation, transdermal, topical and oral drug delivery devices and components.
“We are pleased to have Jim step into this new role within 3M,” said Brad Sauer, executive vice president, 3M Health Care Business. “Jim’s depth of knowledge and understanding of the pharmaceutical industry equip him with outstanding tools to cultivate the innovation that 3M Drug Delivery Systems is known for.”
Ingebrand’s previous positions within the 3M Drug Delivery Systems Division include roles as a key account manager in the UK, an inhalation program manager and a Six Sigma Black Belt. Most recently he served as the global business director for the 3M Dental Division and has worked in several other health care divisions of 3M, including the Infection Prevention Division and Health Care Specialties Division.
